Nifty

:

23398.10

Sensex

:

74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Login

Nifty
Sensex

:
:

23398.10
74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

50/99

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

58.72

11-Sep-2026

Open
High
Low
Previous Close

62.89
62.89
57.07
61.47

Volume
Traded Value (lacs)
52 Week High
52 Week Low

8042
476731.23
82.49
38.33

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

126.71
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

351.42
N/A
-0.76

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

42.10
-4.21
-5.99

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.94
-3.09
-0.97

PAT CAGR (%)

10 Years
5 Years
3 Years

5.14
-1.02
2.95

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-3.64
-2.30
-1.21

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-38.58
-49.93
-72.36

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 6.98 5.48 27.37% 6.81 6.10 11.64% 7.27 11.47 -36.62% 4.17 12.86 -67.57%
Expenses 6.16 7.57 -18.63% 7.68 11.51 -33.28% 6.98 16.18 -56.86% 6.96 15.57 -55.30%
EBITDA 0.83 -2.09 - -0.87 -5.41 - 0.30 -4.72 - -2.79 -2.71 -
EBIDTM 11.83% -38.08% -12.75% -88.64% 4.10% -41.13% -67.03% -21.08%
Other Income 0.16 0.01 1,500.00% 2.00 0.34 488.24% 0.00 0.25 -100.00% 0.01 0.09 -88.89%
Interest 1.88 1.65 13.94% 1.91 1.61 18.63% 1.79 1.56 14.74% 1.73 1.43 20.98%
Depreciation 1.59 1.60 -0.62% 1.57 1.57 0.00% 1.64 1.72 -4.65% 1.62 1.71 -5.26%
PBT -2.49 -5.32 - -2.34 -8.25 - -3.13 -7.74 - -6.14 -5.76 -
Tax 0.00 0.00 0 0.00 0.02 -100.00% 0.00 0.00 0 0.00 0.00 0
PAT -2.49 -5.32 - -2.34 -8.27 - -3.13 -7.74 - -6.14 -5.76 -
PATM -35.60% -97.14% -34.37% -135.54% -42.98% -67.49% -147.42% -44.82%
EPS -1.15 -2.46 - -1.08 -3.83 - -1.45 -3.58 - -2.84 -2.67 -

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 25.23 43.31 50.42 52.13 59.70 53.70 33.41 47.76 33.78 3.53 1.29 Net Sales Growth -29.74% -14.10% -3.28% -12.68% 11.17% 60.73% -30.05% 41.39% 856.94% 173.64% Cost Of Goods Sold 0.51 5.56 6.59 25.68 40.64 25.94 15.86 23.10 12.67 1.20 0.14 Gross Profit 24.72 37.76 43.83 26.46 19.06 27.75 17.55 24.65 21.10 2.33 1.14 GP Margin 97.98% 87.19% 86.93% 50.76% 31.93% 51.68% 52.53% 51.61% 62.46% 66.01% 88.37% Total Expenditure 27.78 58.34 59.15 67.91 93.70 71.28 51.97 57.52 41.28 11.53 13.69 Power & Fuel Cost - 18.52 22.01 14.80 22.23 15.91 10.28 11.70 8.62 0.70 2.87 % Of Sales - 42.76% 43.65% 28.39% 37.24% 29.63% 30.77% 24.50% 25.52% 19.83% 222.48% Employee Cost - 16.30 16.17 15.54 14.96 15.30 14.56 14.41 11.49 5.63 5.67 % Of Sales - 37.64% 32.07% 29.81% 25.06% 28.49% 43.58% 30.17% 34.01% 159.49% 439.53% Manufacturing Exp. - 14.53 11.25 8.48 11.11 10.37 6.77 4.09 4.59 1.07 1.62 % Of Sales - 33.55% 22.31% 16.27% 18.61% 19.31% 20.26% 8.56% 13.59% 30.31% 125.58% General & Admin Exp. - 3.35 3.03 3.25 4.47 3.47 4.05 4.05 3.76 2.88 3.33 % Of Sales - 7.73% 6.01% 6.23% 7.49% 6.46% 12.12% 8.48% 11.13% 81.59% 258.14% Selling & Distn. Exp. - 0.08 0.09 0.16 0.27 0.14 0.16 0.13 0.13 0.05 0.04 % Of Sales - 0.18% 0.18% 0.31% 0.45% 0.26% 0.48% 0.27% 0.38% 1.42% 3.10% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.13 0.29 0.02 0.02 0.01 0.04 % Of Sales - 0% 0% 0% 0% 0.24% 0.87% 0.04% 0.06% 0.28% 1.55% EBITDA -2.53 -15.03 -8.73 -15.78 -34.00 -17.58 -18.56 -9.76 -7.50 -8.00 -12.40 EBITDA Margin -10.03% -34.70% -17.31% -30.27% -56.95% -32.74% -55.55% -20.44% -22.20% -226.63% -961.24% Other Income 2.17 0.71 0.45 0.62 1.16 0.62 0.37 0.33 0.21 0.08 1.03 Interest 7.31 5.91 4.69 2.97 5.39 6.28 6.00 6.29 5.17 3.49 0.74 Depreciation 6.42 6.69 6.77 6.56 6.30 5.12 4.68 4.40 4.15 4.23 4.49 PBT -14.10 -26.92 -19.73 -24.69 -44.53 -28.36 -28.87 -20.12 -16.61 -15.65 -16.60 Tax 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 0.00% -0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT -14.10 -26.94 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 PAT before Minority Interest -14.10 -26.94 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -55.89% -62.20% -39.13% -47.36% -74.59% -52.81% -86.41% -41.90% -52.75% -454.67% -1265.12% PAT Growth 0.00% - - - - - - - - - EPS -6.53 -12.47 -9.13 -11.43 -20.62 -13.13 -13.37 -9.26 -8.25 -7.43 -7.56

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds -146.24 -119.22 -99.46 -75.09 -42.73 -25.00 -14.29 -17.78 1.48 13.01 Share Capital 21.56 21.56 21.56 21.56 19.62 18.00 16.63 13.74 13.74 13.06 Total Reserves -167.80 -140.78 -121.02 -96.65 -66.52 -50.65 -30.92 -31.52 -12.27 -3.72 Non-Current Liabilities 211.75 235.56 225.34 186.83 153.76 115.66 101.79 101.37 88.88 73.88 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.89 5.03 21.40 Unsecured Loans 161.25 183.50 173.25 132.93 100.55 65.51 50.23 49.78 37.76 3.91 Long Term Provisions 3.06 3.05 2.60 2.63 2.56 2.46 4.04 3.68 2.82 3.57 Current Liabilities 103.53 61.83 49.10 78.06 48.19 43.13 54.86 42.28 31.72 29.52 Trade Payables 18.15 18.97 15.28 37.91 20.78 22.65 21.44 17.76 10.99 12.37 Other Current Liabilities 33.63 31.87 22.57 29.01 15.92 18.50 32.00 23.27 19.86 16.34 Short Term Borrowings 50.96 9.93 9.99 9.99 10.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 0.79 1.06 1.26 1.17 1.49 1.99 1.43 1.25 0.87 0.82 Total Liabilities 169.04 178.17 174.98 189.80 159.22 133.79 142.36 125.87 122.08 116.41 Net Block 145.70 149.96 147.31 138.71 117.93 105.29 101.27 100.77 102.17 93.10 Gross Block 314.11 312.46 303.04 287.95 260.88 243.11 234.41 229.51 226.55 213.24 Accumulated Depreciation 168.40 162.50 155.73 149.25 142.95 137.82 133.15 128.74 124.38 120.14 Non Current Assets 158.78 160.73 158.92 154.31 137.80 114.94 111.39 108.64 109.10 107.03 Capital Work in Progress 3.09 2.00 4.09 8.38 11.94 4.19 3.48 3.73 3.50 10.54 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 9.98 8.77 7.52 7.23 7.71 5.24 6.22 3.72 3.23 3.19 Other Non Current Assets 0.00 0.00 0.00 0.00 0.23 0.21 0.42 0.41 0.20 0.20 Current Assets 10.26 17.44 16.06 35.49 21.42 18.86 30.98 17.24 12.97 9.39 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 6.03 9.80 11.95 25.56 16.60 15.00 8.96 11.73 5.45 5.64 Sundry Debtors 0.05 1.90 0.53 0.88 0.30 0.20 2.91 0.32 1.59 0.03 Cash & Bank 0.14 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27 Other Current Assets 4.04 0.54 0.65 0.59 3.80 3.49 1.78 4.77 5.81 3.46 Short Term Loans & Adv. 3.39 5.06 2.85 8.36 3.33 3.18 1.57 4.44 5.67 3.38 Net Current Assets -93.27 -44.39 -33.04 -42.57 -26.77 -24.27 -23.88 -25.04 -18.74 -20.14 Total Assets 169.04 178.17 174.98 189.80 159.22 133.80 142.37 125.88 122.07 116.42

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -7.89 2.36 -24.71 -17.22 -14.57 -35.50 3.90 -6.19 -11.20 -15.26 PBT -26.92 -19.73 -24.69 -44.53 -28.36 -28.87 -20.12 -16.61 -16.05 -16.60 Adjustment 12.41 11.88 9.82 11.41 11.68 8.95 10.31 6.46 10.67 3.45 Changes in Working Capital 6.64 10.21 -9.84 15.90 2.11 -15.58 13.71 9.12 -2.33 -1.38 Cash after chg. in Working capital -7.88 2.36 -24.71 -17.22 -14.57 -35.50 3.90 -1.02 -7.71 -14.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -5.17 -3.49 -0.74 Tax Paid -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.97 -7.82 -12.64 -22.90 -22.55 -10.22 -4.32 -2.77 -4.70 -4.00 Net Fixed Assets -2.74 -7.33 -10.80 -23.51 -25.52 -9.41 -4.65 -3.19 -6.27 -49.48 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -2.23 -0.49 -1.84 0.61 2.97 -0.81 0.33 0.42 1.57 45.48 Cash from Financing Activity 12.86 5.50 37.34 39.51 37.66 28.58 17.32 9.26 15.75 13.22 Net Cash Inflow / Outflow 0.00 0.05 -0.01 -0.61 0.54 -17.14 16.90 0.30 -0.15 -6.04 Opening Cash & Equivalents 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27 6.31 Closing Cash & Equivalent 0.14 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) -67.83 -55.29 -46.13 -34.83 -23.91 -18.14 -8.59 -12.49 1.04 6.91 ROA -15.52% -11.17% -13.54% -25.51% -19.36% -20.91% -14.92% -14.38% -13.46% -14.60% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -296.70% -683.34% ROCE -29.92% -18.99% -28.59% -57.38% -40.28% -56.96% -35.41% -28.95% -27.13% -25.38% Fixed Asset Turnover 0.14 0.16 0.18 0.22 0.21 0.14 0.21 0.15 0.02 0.01 Receivable days 8.23 8.79 4.91 3.60 1.71 17.00 12.36 10.34 83.55 51.87 Inventory Days 66.69 78.69 131.30 128.88 107.38 130.87 79.07 92.84 573.34 1435.63 Payable days 1219.44 948.90 378.02 263.51 305.42 148.85 123.16 120.44 290.43 338.13 Cash Conversion Cycle -1144.52 -861.42 -241.81 -131.03 -196.34 -0.98 -31.73 -17.27 366.46 1149.37 Total Debt/Equity -1.45 -1.62 -1.84 -1.91 -2.37 -2.03 -3.74 -3.16 32.19 3.27 Interest Cover -3.55 -3.21 -7.30 -7.26 -3.52 -3.81 -2.18 -2.45 -3.60 -21.09

Top Investors:

sun pharmaceutical industries ltd

guttikonda rajasekhar

guttikonda vara lakshmi

Annual Reports:

News Update:

Krebs Biochem.&Inds - Quarterly Results
7th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback